Study of Combined Oral Contraceptive Effects in Female Subjects

• Status: Completed
• Trial end date: 2014-08-25

Summary

The purpose of this study is to assess the effect of BMS-955176 on the pharmacokinetics of coadministered oral contraceptives.

• Phase: Phase 1

Details

• Lead Sponsor: Bristol-Myers Squibb; ViiV Healthcare
• Collaborator: GlaxoSmithKline
• Treatments: BMS-955176; Contraceptive Agents; Contraceptives, Oral; Contraceptives, Oral, Combined; Fluoroquinolones; Moxifloxacin; Norgestimate, ethinyl estradiol drug combination